Something Unexpected Is Showing Up in the Research
When GLP-1 medications were developed, they were designed to manage blood sugar and help with weight loss. Nobody expected them to affect cravings for alcohol. But that is exactly what a growing body of research is finding — and for some people, this might be the most meaningful benefit of all.
What the Studies Found
In May 2026, The Lancet published a clinical trial from Copenhagen University Hospital testing semaglutide in people with alcohol use disorder. Over nine weeks, patients on semaglutide drank significantly less and reported fewer cravings compared with those on placebo.
Separately, a massive study of over 600,000 U.S. veterans found that people on GLP-1 medications were 14% less likely to develop problems with alcohol, cannabis, cocaine, nicotine, or opioids compared with people on other diabetes medications. Among veterans who already had substance use issues, GLP-1 use was linked to fewer ER visits, fewer hospitalizations, and even fewer suicidal thoughts.
Why This Might Be Happening
GLP-1 receptors are not just in your gut and pancreas — they are also in brain regions that control reward and craving. The same pathways that drive compulsive eating appear to overlap with those that drive compulsive drinking and drug use. When GLP-1 medications calm the "noise" around food, they may be calming related noise around other substances too.
If this resonates with you:
Many people who start GLP-1 medications notice they are less interested in alcohol without trying to cut back. If that is your experience, you are not imagining it — and you are not alone. This is worth mentioning to your provider, both for your own care and because these real-world observations help researchers understand how these medications work.
What This Does Not Mean
GLP-1 medications are not approved for treating addiction. The alcohol trial was small and short. The veteran study shows correlation, not causation. If you are struggling with alcohol or substance use, GLP-1 medication should complement — never replace — proven treatments like therapy and FDA-approved addiction medications.
But for people carrying the weight of both obesity and problematic drinking, this research offers something that has been in short supply: hope that one treatment might help with both.
Considering GLP-1 Medication?
A telehealth consultation is a good place to discuss your full health picture — weight, cravings, and everything else.
Compare Providers →